Cardioprotection thread, page-838

You should have ended your reply with - ‘and won’t.’
Why would any CEO reply to someone who obviously has a negative bias; especially since the said person has never acknowledged the fact that the treatment arms are for patients who are knocking on heaven’s door due to the fact that they’ve failed all existing forms of SoC.
Also they’re being dosed at the absolute minimum possible until optimum dosage is determined due to its IND designation which BTW is being closely monitored by the FDA. The said person also rarely acknowledges the potential of the other company’s blood borne cancer product.
Now if you want to debate any further go to the other company’s threads.
BTW, I picked up another 5k parcel yesterday.
You do know there’s room for more than one company in the fight against this insidious disease don’t you.
My only post for the day due to golf commitments.